Soy phospholipids (LXR)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameSoy phospholipids (LXR)
Drug Alias Namelysophosphatidic acid (LXR)apoptosis inhibitor (LXR)
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionApoptosis inhibitors
TargetsUpdating
Therapy Area/IndicationsIschemiaReperfusion Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLxr Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLxr Biotechnology Inc
Active IndicationsN/A
Inactive IndicationsIschemiaReperfusion Injury

Other Information

ATC CodeN/A
Related LinksN/A